Literature DB >> 10568141

Bone scintigraphy and metabolic disorders.

C Marì1, A Catafau, I Carriò.   

Abstract

The most important features of bone scintigraphy in metabolic bone disease are its high sensitivity and its capacity to easily image the whole body. Although in the early stages of evolution bone scintigraphy may present difficulties in disease detection because of its usual discrete generalized increased uptake, as the disease progresses, bone scintigraphy has well-recognized appearances, and with the knowledge of the different patterns of abnormality its highest diagnostic value can be obtained. Currently, the main clinical value of bone scan in metabolic bone disease is the detection of focal conditions or focal complications of such generalized disease, its most common use being the detection of fractures in osteoporosis, pseudofractures in osteomalacia and the evaluation of Paget's disease.

Entities:  

Mesh:

Year:  1999        PMID: 10568141

Source DB:  PubMed          Journal:  Q J Nucl Med        ISSN: 1125-0135


  14 in total

1.  Bone scintigraphy: procedure guidelines for tumour imaging.

Authors:  Emilio Bombardieri; Cumali Aktolun; Richard P Baum; Angelika Bishof-Delaloye; John Buscombe; Jean François Chatal; Lorenzo Maffioli; Roy Moncayo; Luc Morteímans; Sven N Reske
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-12       Impact factor: 9.236

2.  SUV measurement of normal vertebrae using SPECT/CT with Tc-99m methylene diphosphonate.

Authors:  Tomohiro Kaneta; Matsuyoshi Ogawa; Hiromitsu Daisaki; Shintaro Nawata; Keisuke Yoshida; Tomio Inoue
Journal:  Am J Nucl Med Mol Imaging       Date:  2016-09-22

Review 3.  Multimodal imaging and treatment of bone metastasis.

Authors:  Eric L Kaijzel; Thomas J A Snoeks; Jeroen T Buijs; Gabri van der Pluijm; Clemens W G M Löwik
Journal:  Clin Exp Metastasis       Date:  2008-10-22       Impact factor: 5.150

4.  Ribbing disease: Uncommon cause of a common symptom.

Authors:  Nishikant Avinash Damle; Manish Patnecha; Praveen Kumar; Ankur Gadodia; Kiran Subbarao; Chandrasekhar Bal
Journal:  Indian J Nucl Med       Date:  2011-01

5.  Advances in drug design of radiometal-based imaging agents for bone disorders.

Authors:  Kazuma Ogawa; Hideo Saji
Journal:  Int J Mol Imaging       Date:  2011-12-15

Review 6.  Well-designed bone-seeking radiolabeled compounds for diagnosis and therapy of bone metastases.

Authors:  Kazuma Ogawa; Atsushi Ishizaki
Journal:  Biomed Res Int       Date:  2015-05-14       Impact factor: 3.411

7.  Studies on the Labeling of Ethylenediaminetetramethylene Phosphonic Acid, Methylene Diphosphonate, Sodium Pyrophosphate and Hydroxyapatite with Lutetium-177 for use in Nuclear Medicine.

Authors:  Imtiaz Ahmed Abbasi
Journal:  World J Nucl Med       Date:  2015 May-Aug

Review 8.  Current imaging techniques in rheumatology: MRI, scintigraphy and PET.

Authors:  Iwona Sudoł-Szopińska; Jarosław B Cwikła
Journal:  Pol J Radiol       Date:  2013-07

9.  Development of novel radiogallium-labeled bone imaging agents using oligo-aspartic acid peptides as carriers.

Authors:  Kazuma Ogawa; Atsushi Ishizaki; Kenichiro Takai; Yoji Kitamura; Tatsuto Kiwada; Kazuhiro Shiba; Akira Odani
Journal:  PLoS One       Date:  2013-12-31       Impact factor: 3.240

10.  Paget's disease diagnosed on bone scintigraphy: Case report and literature review.

Authors:  Avs Anil Kumar; Pg Kumar; Ms Prakash; V Tewari; H Sahni; Ak Dash
Journal:  Indian J Nucl Med       Date:  2013-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.